Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
Saved in:
| Title: | Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]. |
|---|---|
| Authors: | Poh XY; National Centre for Infectious Diseases, Singapore, Singapore., Lee IR; National Centre for Infectious Diseases, Singapore, Singapore., Lim C; National Centre for Infectious Diseases, Singapore, Singapore., Teo J; National Centre for Infectious Diseases, Singapore, Singapore., Rao S; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore., Chia PY; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Ong SWX; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore., Lee TH; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore., Lin RJH; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore., Ng LFP; A*STAR Infectious Diseases Lab, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Ren EC; Singapore Immunology Network, A*STAR, Singapore, Singapore., Lin RTP; National Public Health Laboratory, Singapore, Singapore., Wang LF; Duke-NUS Medical School, Singapore, Singapore., Renia L; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; A*STAR Infectious Diseases Lab, Singapore, Singapore., Lye DC; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Young BE; National Centre for Infectious Diseases, Singapore, Singapore. barnaby_young@ncid.sg.; Tan Tock Seng Hospital, Singapore, Singapore. barnaby_young@ncid.sg.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. barnaby_young@ncid.sg. |
| Source: | Trials [Trials] 2022 Jun 16; Vol. 23 (1), pp. 498. Date of Electronic Publication: 2022 Jun 16. |
| Publication Type: | Clinical Trial Protocol; Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1745-6215 |
|---|---|
| DOI: | 10.1186/s13063-022-06345-2 |
